BIODANE PHARMA A/S
CVR 28310102 · Public limited company (A/S) · Active · Low risk
BIODANE PHARMA A/S is a Public limited company (A/S), founded on , based in Gesten. The company is registered in the industry fremstilling af andre fødevarer i.a.n.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.5m and a net result of DKK 183k.
Bankruptcy risk for BIODANE PHARMA A/S
0.0 × the average (1.41%) · higher risk than 15% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 28310102
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (21 years)
- Address
- Staushedevejen 10
6621 Gesten - Municipality
- Vejen
- Industry
- Fremstilling af andre fødevarer i.a.n. (108900)
Bankruptcies in the industry: Fremstilling af friske bageriprodukter - Share capital
- DKK 552k
- Auditor
- Cedra Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 21 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 67.6% |
| Current ratio | 309% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 2.5m | DKK 2.9m | DKK 3.1m |
| Net profit | DKK 183k | DKK 1.7m | DKK 900k |
| Equity | DKK 2.5m | DKK 2.3m | DKK 3.5m |
| Total assets | DKK 3.7m | DKK 3.4m | DKK 4.3m |
| Cash | DKK 366k | DKK 284k | – |
| Short-term debt | DKK 1.2m | DKK 1.1m | – |
| Avg. employees | 0 | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 148 | ||
| 1 Jan 2024 – 31 Dec 2024 | 143 | ||
| 1 Jan 2023 – 31 Dec 2023 | 148 | ||
| 1 Jan 2022 – 31 Dec 2022 | 159 | ||
| 1 Jan 2021 – 31 Dec 2021 | 150 | ||
| 1 Jan 2020 – 31 Dec 2020 | 134 | ||
| 1 Jan 2019 – 31 Dec 2019 | 148 | ||
| 1 Jan 2018 – 31 Dec 2018 | 136 | ||
| 1 Jan 2017 – 31 Dec 2017 | 135 | ||
| 1 Jan 2016 – 31 Dec 2016 | 146 | ||
| 1 Jan 2015 – 31 Dec 2015 | 141 | ||
| 1 Jan 2014 – 31 Dec 2014 | 147 | ||
| 1 Jan 2013 – 31 Dec 2013 | 147 | ||
| 1 Jan 2012 – 31 Dec 2012 | 113 | ||
| 1 Jan 2011 – 31 Dec 2011 | 130 | ||
| 1 Jan 2010 – 31 Dec 2010 | 137 | ||
| 1 Jan 2009 – 31 Dec 2009 | 124 | ||
| 1 Jan 2008 – 31 Dec 2008 | 134 | ||
| 1 Jan 2007 – 31 Dec 2007 | 147 | ||
| 1 Jan 2006 – 31 Dec 2006 | 142 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Rasmus Juhl Rasmussen | Current | |
| Board | Gunner Kreutzer Jakobsen | Current | |
| Board | Peter Gæmelke | Current | |
| Board | Flemming Torben Heden Knudsen | Current | |
| Board | Michael Prasanjit Baruah | ||
| Board | Lars Jørgen Larsen | ||
| Owner (100%) | BIODAN A/S | Current | |
| Auditor | Cedra Godkendt Revisionsaktieselskab | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | BIOFIBER-DAMINO A/S | Current |
Address history (1 moves)
| Staushedevejen 10, 6621 Gesten | |
| Staushedevejen 10, 6621 Gesten |
Former names
| BIODANE PHARMA A/S | – now |
| BIODANE PHARMA ApS | – |
| BIOFIBER TØRRING ApS | – |
Other companies at the same address
- 31. DECEMBER 2003, GESTEN A/S Opløst
- BIODAN A/S Active
- BIOFIBER A/S Fusioneret
- BIOFIBER-DAMINO A/S Active
Questions and answers about BIODANE PHARMA A/S
Has BIODANE PHARMA A/S gone bankrupt?
No, BIODANE PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BIODANE PHARMA A/S?
Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the auditor of BIODANE PHARMA A/S?
BIODANE PHARMA A/S most recently used Cedra Godkendt Revisionsaktieselskab.
When was BIODANE PHARMA A/S founded?
BIODANE PHARMA A/S was founded on 29 December 2004.
What is the equity of BIODANE PHARMA A/S?
Equity was DKK 2.5m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.